================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 21, 2004
------------------------------
Merck & Co., Inc.
--------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
New Jersey
--------------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
1-3305 22-1109110
------------------------------ ------------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
One Merck Drive, PO Box 100, Whitehouse Station, NJ 08889-0100
--------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's Telephone Number, Including Area Code (908) 423-1000
---------------------------
Not Applicable
--------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
================================================================================
Item 2.02. Results of Operations and Financial Condition.
-----------------------------------------------------------
The following information, including the exhibits hereto, is being furnished
pursuant to this Item 2.02.
Incorporated by reference is a press release issued by the Registrant on October
21, 2004, regarding earnings for the third quarter 2004, attached as Exhibit
99.1. Also incorporated by reference is certain supplemental information not
included in the press release, attached as Exhibit 99.2.
This information shall not be deemed to be "filed" for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
otherwise subject to the liabilities of that Section, and is not incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly set forth by specific reference in such
filing.
Item 9.01. Financial Statements and Exhibits.
---------------------------------------------
(c) Exhibits
--------
Exhibit 99.1 Press release issued October 21, 2004 regarding earnings
for third quarter 2004
Exhibit 99.2 Certain supplemental information not included in the
press release
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Merck & Co., Inc.
Date: October 21, 2004 By: /s/ Debra A. Bollwage
--------------------------
DEBRA A. BOLLWAGE
Assistant Secretary
EXHIBIT INDEX
-------------
Exhibit
Number Description
------ -----------
99.1 Press release issued October 21, 2004 regarding earnings for
third quarter 2004
99.2 Certain supplemental information not included in the press release